WELL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
BUY now. Price action is bullish-to-neutral but improving (above pivot with a positive, expanding MACD), options volume leans bullish, hedge funds are accumulating, and Wall Street targets still imply meaningful upside versus $187.70. With no Intellectia AI Stock Picker/SwingMax signals today, this is not a “must-buy” tactical signal trade, but it still grades as a good buy right now for an impatient investor seeking near-term continuation toward the $190.5–$193 resistance zone and potential multi-month upside into 2026 catalysts.
Trend/Setup: WELL closed at $187.70 (+1.44%) and is trading just above the pivot ($186.44), suggesting bulls are defending the current zone. Momentum: MACD histogram is positive (0.227) and expanding, supporting upside continuation. RSI(6) at ~66.4 is upper-neutral (not an outright overbought reversal signal, but near-term upside may be choppier). Moving averages are converging, consistent with consolidation that is starting to resolve upward. Levels: Support S1 ~$182.36 (then S2 ~$179.84). Resistance R1 ~$190.52, then R2 ~$193.04. Near-term bias is upward while holding above the ~$186.4 pivot.
Senior housing operating backdrop: multiple analysts highlight multi-year growth and margin upside potential in senior housing operating portfolios.
Sector/macro tailwinds: expectations for more supportive macro conditions in 2026, easing supply pressures, and a potentially more stable political backdrop (per UBS/Cantor commentary).
Strategic/operational drivers: continued expansion of Welltower’s end-to-end tech platform to additional operators (Jefferies) and an improving M&A theme for REITs (Cantor).
Flow/support: hedge funds are buying, with reported buying amount up ~104% over the last quarter.
Event catalyst: next earnings (QDEC
on 2026-02-10 after hours.
Profitability pressure in latest reported quarter: despite strong revenue growth, net income and EPS declined materially YoY, which can cap near-term multiple expansion.
Technical ceiling nearby: price is approaching resistance at ~$190.5 and ~$193, where selling pressure can appear.
Analyst dissent: JPMorgan downgraded to Neutral (even while keeping a $205 target), indicating some valuation/return expectations are more tempered at current levels.
No supportive near-term news flow: no notable news in the last week, so momentum is primarily technical/positioning-driven.
Latest quarter: 2025/Q3. Revenue grew strongly to ~$2.686B (+30.65% YoY), indicating robust top-line momentum. However, net income fell to ~$280.6M (-37.63% YoY) and EPS dropped to $0.41 (-43.84% YoY), showing weaker bottom-line conversion. Gross margin improved to ~22.3% (+4.40% YoY), a constructive sign for operating efficiency/mix even though earnings were down YoY.
Recent trend: Price targets were generally revised upward into late 2025 (e.g., BofA to $260 from $246; Jefferies to $231 from $210; UBS to $232 from $203; Wells Fargo to $218 from $200; Morgan Stanley to $200 from $170), reflecting improving conviction in senior housing fundamentals and margin upside. In Dec 2025, JPMorgan downgraded WELL to Neutral (PT $205), introducing a more cautious tone. Early Jan 2026 updates were mixed but still constructive: Cantor raised PT to $204 (Overweight), while UBS trimmed PT slightly to $228 (still Buy). Wall Street pros: multi-year senior housing growth, margin upside, tech platform expansion, and sector tailwinds into 2026. Cons: some valuation/return caution (JPM Neutral) and weaker YoY EPS/net income in the latest quarter.
